For Asacol™, we are currently looking for distribution partners in certain countries in: Central and Eastern European markets, South American markets and some Asian countries.

For TP05, we are currently looking for a licensing partner in the USA.

Distribution or licensing rights for Colpermin™ (OTC) are available for selected countries (North America and Europe: not including UK, Ireland, Germany, Austria and Switzerland).

We acquired Entocort® in 2015 as a perfect fit for our geographic expansion strategy and to enhance our GI portfolio. It is Tillotts Pharma’s intention to realise the potential of Entocort® and also to grow Entocort® with active life-cycle programmes. We are currently looking for marketing partners in selected countries outside the USA and Japan.